Page last updated: 2024-08-23

diltiazem and moricizine

diltiazem has been researched along with moricizine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Benedek, IH; Davidson, AF; Flamenbaum, W; Pieniaszek, HJ; Robinson, CA; Shum, L; Widner, PJ1

Reviews

1 review(s) available for diltiazem and moricizine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for diltiazem and moricizine

ArticleYear
Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Area Under Curve; Biotransformation; Blood Proteins; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Diltiazem; Drug Interactions; Half-Life; Humans; Male; Moricizine; Protein Binding

1996

Other Studies

2 other study(ies) available for diltiazem and moricizine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004